BSE filing, NSE: LINKPH. Summary written from the filing by ALFA Finder's alert engine.
Link Pharma Chem Ltd: key numbers
- Share price
- ₹24.05
- Market cap
- ₹10.68 Cr
- Revenue (annual)
- ₹27.43 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- -1642.8×Sector 33.6×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Link Pharma Chem Ltd
All →Link Pharma Chem Q2 FY27 Results: Net Loss of ₹0.2 Cr
Link Pharma Chem approved unaudited results for the quarter and half year ended 30 September 2026. Revenue was Rs.533.13 Lakh with a loss of Rs.22.31 Lakh for the quarter.
- Key figure
- Net loss ₹0.2 Cr
Link Pharma Chem Board Meeting Date
Link Pharma Chem's board meets on 3 November 2026 to approve unaudited half-year results. The trading window stays closed until results are declared.
Link Pharma Chem Other Announcement
Link Pharma Chem Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure provides the updated ownership structure for the company.
Link Pharma Chem Legal & Regulatory
Link Pharma Chem Ltd received a GST order reducing the total demand and penalty for FY 2021-22. The company plans to appeal the decision.
- Value
- ₹0.18 Cr
Link Pharma Chem Management Change
Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.
Link Pharma Chem Annual General Meeting
Link Pharma Chem Ltd. held its 41st Annual General Meeting on August 20, 2026, where shareholders transacted various ordinary and special business items.
Other other announcement announcements
All →Sundrop Brands Other Announcement
Sundrop Brands Limited announced that its Registrar and Share Transfer Agent, KFin Technologies Limited, is shifting its corporate office. The change takes effect on December 01, 2026.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has fully utilized its IPO proceeds totaling Rs. 680 Crore as of September 30, 2026. Consequently, further monitoring agency reports are no longer required.
- Value
- ₹680.0 Cr
DSJ Keep Learning Other Announcement
DSJ Keep Learning Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing reports promoter and public holdings with no transaction or monetary amount involved.
RBZ Jewellers Other Announcement
RBZ Jewellers Limited has reconstituted its Audit, Nomination and Remuneration, and Stakeholder Relationship Committees. Mr. Rajiv Mehta, an Independent Director, was appointed as a member of these committees.
Vidya Wires Other Announcement
Vidya Wires intimated a scheduled TV interview with Zee Business on 5 Nov 2026. No UPSI is expected to be disclosed.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited filed its half-yearly shareholding pattern under Regulation 31(1)(b) for the period ended 30 September 2026. The filing shows promoter and public holdings, with no transaction or corporate event.